Evolent Health (EVH) EBITDA margin US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
EBITDA margin, % | ? | -7.73% | 2.31% | 9.94% | 0.54% | 2.36% | 5.61% | |
Changes by years, y/y, % | -6pp | +10pp | +8pp | -9pp | +2pp |
Evolent Health. EBITDA margin, %
Evolent Health. EBITDA margin, changes, pp
Evolent Health (EVH) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
EBITDA margin, % | ? | 5.87% | 5.78% | 4.81% | 5.52% | 6.25% | 5.61% | |
Changes by years, y/y, % | +2pp | +13pp | +5pp | +14pp | +0pp | |||
Changes by quarters, q/q, % | +15pp | 0pp | -1pp | +1pp | +1pp |